Newsfiscal.ai
Eos SENOLYTIX Presents Preclinical Data for PTC-2105 at World Congress on Targeting Mitochondria
· Published
Article summary
Eos SENOLYTIX, Inc. shared new preclinical data for its lead candidate, PTC-2105, while providing a reminder to Pulmatrix stockholders regarding the pending merger.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…